propranolol has been researched along with Flushing in 9 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Flushing: A transient reddening of the face that may be due to fever, certain drugs, exertion, or stress.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Flushing has been associated with medications, rosacea, menopause, carcinoid syndrome, pheochromocytoma, polycythemia, and mastocytosis, although it can occur without known cause." | 5.33 | Symptomatic treatment of idiopathic and rosacea-associated cutaneous flushing with propranolol. ( Cohen, JB; Craige, H, 2005) |
| "Flushing and erythema are frequent skin symptoms in rosacea." | 2.66 | Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action. ( Driessen, RJB; Logger, JGM; Olydam, JI, 2020) |
| "Pretreatment with indomethacin or L-Nomega-nitroarginine methylester (L-NAME) abolished U-II-induced ear flushing." | 1.34 | Urotensin-II induces ear flushing in rats. ( Andrade-Gordon, P; Colburn, R; Damiano, BP; Haertlein, B; Minor, LK; Parry, TJ; Qi, JS; Schulingkamp, R; Stone, D, 2007) |
| "Flushing has been associated with medications, rosacea, menopause, carcinoid syndrome, pheochromocytoma, polycythemia, and mastocytosis, although it can occur without known cause." | 1.33 | Symptomatic treatment of idiopathic and rosacea-associated cutaneous flushing with propranolol. ( Cohen, JB; Craige, H, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Logger, JGM | 1 |
| Olydam, JI | 1 |
| Driessen, RJB | 1 |
| Naharro-Fernández, C | 1 |
| de Quintana-Sancho, A | 1 |
| López-Sundh, AE | 1 |
| Reguero-Del Cura, L | 1 |
| Gónzalez-López, MA | 1 |
| Craige, H | 1 |
| Cohen, JB | 1 |
| Qi, JS | 1 |
| Schulingkamp, R | 1 |
| Parry, TJ | 1 |
| Colburn, R | 1 |
| Stone, D | 1 |
| Haertlein, B | 1 |
| Minor, LK | 1 |
| Andrade-Gordon, P | 1 |
| Damiano, BP | 1 |
| Brommer, EJ | 1 |
| Derkx, FH | 1 |
| Barrett-Bergshoeff, MM | 1 |
| Schalekamp, MA | 1 |
| Guivernau, M | 1 |
| Quintanilla, ME | 1 |
| Tampier, L | 1 |
| Drummond, PD | 1 |
| Sandroni, P | 1 |
| Novak, V | 1 |
| Opfer-Gehrking, TL | 1 |
| Huck, CA | 1 |
| Low, PA | 1 |
| Hom, GJ | 1 |
| Forrest, MJ | 1 |
| Bach, TJ | 1 |
| Brady, E | 1 |
| Candelore, MR | 1 |
| Cascieri, MA | 1 |
| Fletcher, DJ | 1 |
| Fisher, MH | 1 |
| Iliff, SA | 1 |
| Mathvink, R | 1 |
| Metzger, J | 1 |
| Pecore, V | 1 |
| Saperstein, R | 1 |
| Shih, T | 1 |
| Weber, AE | 1 |
| Wyvratt, M | 1 |
| Zafian, P | 1 |
| MacIntyre, DE | 1 |
1 review available for propranolol and Flushing
| Article | Year |
|---|---|
Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Bradycardia; Carvedilol; Dermatologic Agents; Dru | 2020 |
1 trial available for propranolol and Flushing
| Article | Year |
|---|---|
The effect of adrenergic blockade on blushing and facial flushing.
Topics: Adolescent; Adult; Blushing; Female; Flushing; Forehead; Humans; Male; Phentolamine; Propranolol | 1997 |
7 other studies available for propranolol and Flushing
| Article | Year |
|---|---|
Successful treatment of idiopathic Harlequin Syndrome with oxybutynin and propranolol.
Topics: Autonomic Nervous System Diseases; Female; Flushing; Humans; Hypohidrosis; Mandelic Acids; Middle Ag | 2021 |
Symptomatic treatment of idiopathic and rosacea-associated cutaneous flushing with propranolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Female; Flushing; Humans; Male; Middle Aged; Propranolol; | 2005 |
Urotensin-II induces ear flushing in rats.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Temperature; Cal | 2007 |
The inability of propranolol and aspirin to inhibit the response of fibrinolytic activity and factor VIII-antigen to infusion of DDAVP.
Topics: Antigens; Arginine Vasopressin; Aspirin; Blood Pressure; Deamino Arginine Vasopressin; Factor VIII; | 1984 |
Investigations on the ethanol-induced flushing reaction: effects of propranolol and dipyridamole on acetaldehyde and prostacyclin metabolism.
Topics: Acetaldehyde; Aldehyde Dehydrogenase; Animals; Dipyridamole; Epoprostenol; Ethanol; Flushing; Male; | 1994 |
Mechanisms of blood pressure alterations in response to the Valsalva maneuver in postural tachycardia syndrome.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Blood Pressure; Cardiovascular Sys | 2000 |
Beta(3)-adrenoceptor agonist-induced increases in lipolysis, metabolic rate, facial flushing, and reflex tachycardia in anesthetized rhesus monkeys.
Topics: Adenylyl Cyclases; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Anesthesia; Animal | 2001 |